Investors in drone manufacturer AeroVironment were met with a starkly different narrative last week. Rather than delivering on anticipated growth, the company reported the loss of a significant government program, a sharp reduction in its financial outlook, and deeply negative quarterly results. As management works to contain the fallout, an upcoming investor conference is set to be a critical test for their recovery strategy.
Operational Strength Amidst Setback
Despite the recent blow, AeroVironment’s core business demonstrates underlying resilience. The company’s funded backlog recently reached a record $1.1 billion. Strong demand for its systems is evidenced by several recent contract awards:
- $186 million: A production order for the Switchblade 600 Block 2 and Switchblade 300 Block 20 loitering munition systems.
- $97.4 million: A three-year agreement with the U.S. Army for the development of the GENESIS test environment for sensor validation.
To meet this sustained demand, the corporation is undertaking significant capacity expansion. Over $30 million is being invested to enlarge three facilities in Albuquerque, supported by state funding. Concurrently, a new production site is under development in Utah, designed with an annual output capacity exceeding $2 billion in product value.
A Costly Termination and Revised Guidance
The immediate catalyst for the stock’s decline was the unexpected termination of the existing SCAR program agreement. The U.S. government announced the dissolution of the so-called BADGER contract. For AeroVironment, this action necessitates the removal of options worth approximately $1.5 billion from its unfunded backlog. While the firm remains eligible to bid on future SCAR-related contracts, it now anticipates revenue of under $100 million from this segment for fiscal year 2026.
In direct response, management slashed its full-year revenue forecast to $1.9 billion. Adjusted earnings per share expectations were cut by nearly 16%. The financial results for the third quarter already fell short of Wall Street estimates. A non-cash goodwill impairment charge of $151.3 million pushed the company deep into the red, resulting in a net loss of $156.6 million for the period.
Market disappointment is reflected in the share price performance. Since the start of the year, the equity has shed nearly 17% of its value. On Friday, shares closed at 181.45 euros, representing a substantial discount to the 52-week high of over 354 euros.
Leadership Transition and Forthcoming Scrutiny
Adding to the operational challenges is an impending change in the executive suite. Chief Financial Officer Kevin McDonnell, who has been instrumental in strengthening the balance sheet and guiding strategic acquisitions since joining in 2020, will retire at the end of July 2026. A search for his successor is already underway.
All eyes are now on the J.P. Morgan Industrials Conference scheduled for Wednesday, March 18. During the scheduled fireside chat, CEO Wahid Nawabi and the outgoing CFO McDonnell will face pressing questions from analysts. They are expected to present concrete plans for offsetting the lost SCAR revenue, stabilizing the gross margin—which has fallen from 38% to 24%—and securing profitability for the upcoming fiscal year.
